Shopping Cart 0
Cart Subtotal
AED 0

Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Insulet Corp (PODD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetics. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.

Insulet Corp Key Recent Developments

May 02,2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA

May 02,2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year

Feb 25,2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%

Jan 28,2019: Insulet names Corinne Nevinny as board director

Jan 07,2019: Insulet names Wayde McMillan as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Insulet Corp-Key Facts

Insulet Corp-Key Employees

Insulet Corp-Key Employee Biographies

Insulet Corp-Major Products and Services

Insulet Corp-History

Insulet Corp-Company Statement

Insulet Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Insulet Corp-Business Description

Business Segment: Drug Delivery

Performance

Business Segment: International Omnipod

Performance

Business Segment: US Omnipod

Performance

Geographical Segment: All other

Performance

Geographical Segment: United States

Performance

R&D Overview

Insulet Corp-Corporate Strategy

Insulet Corp-SWOT Analysis

SWOT Analysis-Overview

Insulet Corp-Strengths

Insulet Corp-Weaknesses

Insulet Corp-Opportunities

Insulet Corp-Threats

Insulet Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Insulet Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA

May 02, 2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year

Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%

Jan 28, 2019: Insulet names Corinne Nevinny as board director

Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer

Nov 01, 2018: Insulet reports third quarter 2018 revenue of USD 151.1 million, up 24% year-over-year, and gross margin over 67%, up 700 basis points

Sep 11, 2018: Insulet Appoints Shacey Petrovic as Chief Executive Officer

Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018

Aug 02, 2018: Insulet Reports second quarter 2018 revenue of USD 124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points

May 03, 2018: Insulet Reports First Quarter 2018 Financial Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Insulet Corp, Performance Chart (2014-2018)

Insulet Corp, Ratio Charts

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Insulet Corp, Key Facts

Insulet Corp, Key Employees

Insulet Corp, Key Employee Biographies

Insulet Corp, Major Products and Services

Insulet Corp, History

Insulet Corp, Other Locations

Insulet Corp, Subsidiaries

Insulet Corp, Key Competitors

Insulet Corp, Ratios based on current share price

Insulet Corp, Annual Ratios

Insulet Corp, Annual Ratios (Cont...1)

Insulet Corp, Interim Ratios

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Insulet Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Insulet Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

West Pharmaceutical Services Inc

Valeritas Inc

Tandem Diabetes Care Inc

Owen Mumford Inc

Medtronic MiniMed Inc

Company Profile

Company Profile Title

Insulet Corp (PODD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetics. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.

Insulet Corp Key Recent Developments

May 02,2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA

May 02,2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year

Feb 25,2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%

Jan 28,2019: Insulet names Corinne Nevinny as board director

Jan 07,2019: Insulet names Wayde McMillan as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Insulet Corp-Key Facts

Insulet Corp-Key Employees

Insulet Corp-Key Employee Biographies

Insulet Corp-Major Products and Services

Insulet Corp-History

Insulet Corp-Company Statement

Insulet Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Insulet Corp-Business Description

Business Segment: Drug Delivery

Performance

Business Segment: International Omnipod

Performance

Business Segment: US Omnipod

Performance

Geographical Segment: All other

Performance

Geographical Segment: United States

Performance

R&D Overview

Insulet Corp-Corporate Strategy

Insulet Corp-SWOT Analysis

SWOT Analysis-Overview

Insulet Corp-Strengths

Insulet Corp-Weaknesses

Insulet Corp-Opportunities

Insulet Corp-Threats

Insulet Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Insulet Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA

May 02, 2019: Insulet Reports First Quarter 2019 Revenue of USD 159.6 Million, an Increase of 29% Year-Over-Year

Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of USD 164.9 million, up 26% year-over-year, and full year 2018 revenue of USD 563.8 million, up 22%

Jan 28, 2019: Insulet names Corinne Nevinny as board director

Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer

Nov 01, 2018: Insulet reports third quarter 2018 revenue of USD 151.1 million, up 24% year-over-year, and gross margin over 67%, up 700 basis points

Sep 11, 2018: Insulet Appoints Shacey Petrovic as Chief Executive Officer

Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018

Aug 02, 2018: Insulet Reports second quarter 2018 revenue of USD 124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points

May 03, 2018: Insulet Reports First Quarter 2018 Financial Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Insulet Corp, Performance Chart (2014-2018)

Insulet Corp, Ratio Charts

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Insulet Corp, Key Facts

Insulet Corp, Key Employees

Insulet Corp, Key Employee Biographies

Insulet Corp, Major Products and Services

Insulet Corp, History

Insulet Corp, Other Locations

Insulet Corp, Subsidiaries

Insulet Corp, Key Competitors

Insulet Corp, Ratios based on current share price

Insulet Corp, Annual Ratios

Insulet Corp, Annual Ratios (Cont...1)

Insulet Corp, Interim Ratios

Insulet Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Insulet Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Insulet Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Insulet Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

West Pharmaceutical Services Inc

Valeritas Inc

Tandem Diabetes Care Inc

Owen Mumford Inc

Medtronic MiniMed Inc